Literature DB >> 16799888

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Yuichiro Eguchi1, Takahisa Eguchi, Toshihiko Mizuta, Yasushi Ide, Tsutomu Yasutake, Ryuichi Iwakiri, Akitaka Hisatomi, Iwata Ozaki, Kyousuke Yamamoto, Yoichiro Kitajima, Yasunori Kawaguchi, Shigetaka Kuroki, Naofumi Ono.   

Abstract

BACKGROUND: Nonalcoholic fatty liver diseases are often associated with obesity, insulin resistance, and excessive visceral fat accumulation. The aims of this study were (1) to evaluate the relationship between the severity of fatty liver and visceral fat accumulation in nonalcoholic fatty liver diseases, and (2) to investigate the relationships of fatty liver with biochemical data and insulin resistance.
METHODS: One hundred twenty-nine subjects (63 women) with fatty liver diagnosed by ultrasonography were enrolled. Subjects positive for hepatitis B virus, hepatitis C virus, or autoimmune antibodies and those whose alcohol intake was over 20 g/day were excluded. The visceral fat area at the umbilical level and the liver-spleen ratio were evaluated by computed tomography.
RESULTS: The severity of fatty liver evaluated by ultrasonography showed a significant positive relationship with the visceral fat area and waist circumstance (fatty liver severity: mild, 92.0 +/- 30.9 cm(2); moderate, 122.1 +/- 32.6 cm(2); severe, 161.0 +/- 48.4 cm(2); P < 0.0001). The visceral fat area and liver-spleen ratio were negatively correlated (r = -0.605, P < 0.0001). The severity of fatty liver showed strong positive relationships with serum aspartate aminotransferase, alanine aminotransferase, fasting plasma glucose, fasting plasma insulin, and insulin resistance. The severity of fatty liver was positively related to the visceral fat area in 49 nonobese subjects (body mass index <25).
CONCLUSIONS: The severity of fatty liver was positively correlated with visceral fat accumulation and insulin resistance in both obese and nonobese subjects, suggesting that hepatic fat infiltration in nonalcoholic fatty liver disease may be influenced by visceral fat accumulation regardless of body mass index.

Entities:  

Mesh:

Year:  2006        PMID: 16799888     DOI: 10.1007/s00535-006-1790-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  29 in total

1.  Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.

Authors:  H Nagaretani; T Nakamura; T Funahashi; K Kotani; M Miyanaga; K Tokunaga; M Takahashi; H Nishizawa; K Kishida; H Kuriyama; K Hotta; S Yamashita; Y Matsuzawa
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Authors:  Amy Berrington de González; Sarah Darby
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

4.  Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

Authors:  Saverio Stranges; Joan M Dorn; Paola Muti; Jo L Freudenheim; Eduardo Farinaro; Marcia Russell; Thomas H Nochajski; Maurizio Trevisan
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

5.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.

Authors:  Sei-Ichiro Kojima; Norihito Watanabe; Makoto Numata; Tetsuhei Ogawa; Shohei Matsuzaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

6.  Body mass index as a predictor of hepatic steatosis in living liver donors.

Authors:  M E Rinella; E Alonso; S Rao; P Whitington; J Fryer; M Abecassis; R Superina; S L Flamm; A T Blei
Journal:  Liver Transpl       Date:  2001-05       Impact factor: 5.799

7.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.

Authors:  Darcy B Carr; Kristina M Utzschneider; Rebecca L Hull; Keiichi Kodama; Barbara M Retzlaff; John D Brunzell; Jane B Shofer; Brian E Fish; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

Review 10.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

View more
  97 in total

1.  Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Shingo Hibino; Akira Yamanoi
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

2.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

3.  Nonalcoholic fatty liver disease among HIV-infected persons.

Authors:  Nancy Crum-Cianflone; Angelica Dilay; Gary Collins; Dean Asher; Richard Campin; Sheila Medina; Zach Goodman; Robin Parker; Alan Lifson; Thomas Capozza; Mary Bavaro; Braden Hale; Charles Hames
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

4.  Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.

Authors:  Yumi Kobayashi; Yasunori Kawaguchi; Toshihiko Mizuta; Takuya Kuwashiro; Satoshi Oeda; Noriko Oza; Hirokazu Takahashi; Shinji Iwane; Yuichiro Eguchi; Keizo Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2010-11-03       Impact factor: 7.527

5.  The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Toshihiko Mizuta; Yoshio Sumida; Eriko Ishibashi; Yoichiro Kitajima; Hiroshi Isoda; Hiroko Horie; Takaya Tashiro; Eri Iwamoto; Hirokazu Takahashi; Takuya Kuwashiro; Shu Soejima; Yasunori Kawaguchi; Yasutomo Oda; Sei Emura; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Keizo Anzai; Kazuma Fujimoto; Shunzo Koizumi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

6.  Effectiveness of thigh-to-thigh current path for the measurement of abdominal fat in bioelectrical impedance analysis.

Authors:  Ki Hwan Hong; Yong Gyu Lim; Kwang Suk Park
Journal:  Med Biol Eng Comput       Date:  2009-11-04       Impact factor: 2.602

7.  Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.

Authors:  Yasushi Imamura; Hirofumi Uto; Yasunari Hiramine; Kaori Hosoyamada; Sho Ijuin; Shiro Yoshifuku; Hironori Miyahara; Shigeho Maenohara; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-10-31       Impact factor: 7.527

8.  Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.

Authors:  Rui Wang; Qiang Lu; Ji Feng; Fuzai Yin; Chunmei Qin; Bo Liu; Yali Liu; Xiaoli Liu
Journal:  Endocrine       Date:  2011-07-28       Impact factor: 3.633

9.  Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.

Authors:  Charlene A Wong; Maria Rosario G Araneta; Elizabeth Barrett-Connor; John Alcaraz; Donna Castañeda; Carol Macera
Journal:  Diabetes Res Clin Pract       Date:  2007-08-30       Impact factor: 5.602

10.  Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Authors:  Ryan L McKimmie; Kurt R Daniel; J Jeffrey Carr; Donald W Bowden; Barry I Freedman; Thomas C Register; Fang-Chi Hsu; Kurt K Lohman; Richard B Weinberg; Lynne E Wagenknecht
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.